面部移植的风险概况与其他类型的血管化复合性全移植手术相比 - 一个回顾性的多中心分析
Jillian Dean1, Tobias Niederegger2, Thomas Schaschinger2
1University of Pittsburgh School of Medicine, Pittsburgh, PA.
The Journal of craniofacial surgery
|January 6, 2026
概括
面部血管化复合性全移植 (FVCA) 患者比其他类型的VCA体验更多的排斥发作和住院治疗. 由于感染并发症率较高,FVCA需要加强免疫抑制和监测.
科学领域:
- 重建性手术是一种重建性手术.
- 移植免疫学 移植免疫学
- 器官移植 器官移植
背景情况:
- 血管化复合性全体移植 (VCA) 为严重创伤提供功能和心理恢复.
- 面部VCA (FVCA) 是复杂的,可能导致严重的排斥并发症.
- 有限的研究将FVCA结果与其他VCA类型进行比较.
研究的目的:
- 为了比较面部血管化复合性全移植 (FVCA) 和非FVCA手术之间的结果.
- 确定与FVCA相关的特定挑战和并发症率.
主要方法:
- 使用了来自器官采购和移植网络 (OPTN) 数据库的数据.
- 包括96个VCA案件:16个FVCA和80个非FVCA.
- 分析了排斥事件,住院和并发症率.
主要成果:
- 接受FVCA的患者有明显更多的急性排斥发作 (中位数为5.0对0.0,P=0.0022).
- 在FVCA患者中,住院次数较多 (中位数为3.0对0.0,P<0.001).
- 在FVCA接受者中,感染性并发症更频繁 (44%对15%,P=0.015).
结论:
- FVCA带来了独特的免疫挑战,包括高抗原性和预敏感患者.
- 因此,FVCA需要加强免疫抑制和术后监测.
- 优化管理策略对于改善FVCA结果和患者安全至关重要.
更多相关视频
05:34A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies
Published on: March 31, 2022
2.7K
09:36Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research
Published on: April 26, 2019
6.1K
相关概念视频
01:24Tissue Transplantation
888
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
888
01:28Kidney Transplant I: Introduction
333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333